These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28678619)

  • 1. High retention in HIV care at a tertiary care centre in Toronto, Canada.
    Szadkowski L; Walmsley S; Burchell AN; Collins E; Rourke SB; Raboud J;
    AIDS Care; 2018 Feb; 30(2):246-254. PubMed ID: 28678619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social determinants of health and retention in HIV care in a clinical cohort in Ontario, Canada.
    Rachlis B; Burchell AN; Gardner S; Light L; Raboud J; Antoniou T; Bacon J; Benoit A; Cooper C; Kendall C; Loutfy M; Wobeser W; McGee F; Rachlis A; Rourke SB;
    AIDS Care; 2017 Jul; 29(7):828-837. PubMed ID: 28027668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries.
    Raboud JM; Loutfy MR; Su D; Bayoumi AM; Klein MB; Cooper C; Machouf N; Rourke S; Walmsley S; Rachlis A; Harrigan PR; Smieja M; Tsoukas C; Montaner JS; Hogg RS;
    BMC Infect Dis; 2010 Feb; 10():40. PubMed ID: 20184766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the HIV Care Continuum in Latin America: progress in clinical retention, cART use and viral suppression.
    Rebeiro PF; Cesar C; Shepherd BE; De Boni RB; Cortés CP; Rodriguez F; Belaunzarán-Zamudio P; Pape JW; Padgett D; Hoces D; McGowan CC; Cahn P
    J Int AIDS Soc; 2016; 19(1):20636. PubMed ID: 27065108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Prediction Tool for Medical Appointment Attendance Among HIV-Infected Persons with Unsuppressed Viremia.
    Woodward B; Person A; Rebeiro P; Kheshti A; Raffanti S; Pettit A
    AIDS Patient Care STDS; 2015 May; 29(5):240-7. PubMed ID: 25746288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of retention in early HIV medical care on viro-immunological parameters and survival: a statewide study.
    Tripathi A; Youmans E; Gibson JJ; Duffus WA
    AIDS Res Hum Retroviruses; 2011 Jul; 27(7):751-8. PubMed ID: 21142607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor retention in care one-year after viral suppression: a significant predictor of viral rebound.
    Crawford TN
    AIDS Care; 2014; 26(11):1393-9. PubMed ID: 24848440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PositiveLinks: A Mobile Health Intervention for Retention in HIV Care and Clinical Outcomes with 12-Month Follow-Up.
    Dillingham R; Ingersoll K; Flickinger TE; Waldman AL; Grabowski M; Laurence C; Wispelwey E; Reynolds G; Conaway M; Cohn WF
    AIDS Patient Care STDS; 2018 Jun; 32(6):241-250. PubMed ID: 29851504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Representativeness of an HIV cohort of the sites from which it is recruiting: results from the Ontario HIV Treatment Network (OHTN) cohort study.
    Raboud J; Su D; Burchell AN; Gardner S; Walmsley S; Bayoumi AM; Blitz S; Cooper C; Salit I; Cohen J; Rourke SB; Loutfy MR
    BMC Med Res Methodol; 2013 Mar; 13():31. PubMed ID: 23496868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention.
    Mugavero MJ; Amico KR; Westfall AO; Crane HM; Zinski A; Willig JH; Dombrowski JC; Norton WE; Raper JL; Kitahata MM; Saag MS
    J Acquir Immune Defic Syndr; 2012 Jan; 59(1):86-93. PubMed ID: 21937921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City.
    Robertson M; Laraque F; Mavronicolas H; Braunstein S; Torian L
    AIDS Care; 2015; 27(2):260-7. PubMed ID: 25244545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring retention in HIV care: the elusive gold standard.
    Mugavero MJ; Westfall AO; Zinski A; Davila J; Drainoni ML; Gardner LI; Keruly JC; Malitz F; Marks G; Metsch L; Wilson TE; Giordano TP;
    J Acquir Immune Defic Syndr; 2012 Dec; 61(5):574-80. PubMed ID: 23011397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort.
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):772-81. PubMed ID: 27030657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in HIV Continuum of Care Outcomes over Ten Years of Follow-Up at a Large HIV Primary Medical Home in the Southeastern United States.
    Ghiam MK; Rebeiro PF; Turner M; Rogers WB; Bebawy SS; Raffanti SP; Person AK; Pettit AC
    AIDS Res Hum Retroviruses; 2017 Oct; 33(10):1027-1034. PubMed ID: 28462622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation and Operational Research: Engagement in HIV Care Among Persons Enrolled in a Clinical HIV Cohort in Ontario, Canada, 2001-2011.
    Burchell AN; Gardner S; Light L; Ellis BM; Antoniou T; Bacon J; Benoit A; Cooper C; Kendall C; Loutfy M; McGee F; Raboud J; Rachlis A; Wobeser W; Rourke SB
    J Acquir Immune Defic Syndr; 2015 Sep; 70(1):e10-9. PubMed ID: 26322672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the care cascade after antiretroviral therapy initiation in Latin America.
    Wolff MJ; Cortes CP; Mejìa FA; Padgett D; Belaunzarán-Zamudio P; Grinsztejn B; Giganti MJ; McGowan CC; Rebeiro PF;
    Int J STD AIDS; 2018 Jan; 29(1):4-12. PubMed ID: 28618980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Poor Retention in Care of HIV-infected Patients Receiving Antiretroviral Therapy in Korea: Five-Year Hospital-based Retrospective Cohort Study.
    Lee S; Lee SH; Lee SJ; Kim KH; Lee JE; Cho H; Lee SG; Chen DH; Chung JS; Kwak IS
    J Korean Med Sci; 2016 Mar; 31(3):376-81. PubMed ID: 26955237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care.
    McCombe JA; Vivithanaporn P; Gill MJ; Power C
    HIV Med; 2013 Feb; 14(2):99-107. PubMed ID: 22994556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once daily dosing improves adherence to antiretroviral therapy.
    Raboud J; Li M; Walmsley S; Cooper C; Blitz S; Bayoumi AM; Rourke S; Rueda S; Rachlis A; Mittmann N; Smieja M; Collins E; Loutfy MR
    AIDS Behav; 2011 Oct; 15(7):1397-409. PubMed ID: 20878227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.